Clinical Trials
2
Active:0
Completed:0
Trial Phases
2 Phases
Early Phase 1:1
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Early Phase 1
1 (50.0%)Phase 1
1 (50.0%)Study for the Prevention of Oral Mucositis (SPOM)
- First Posted Date
- 2022-04-21
- Last Posted Date
- 2023-09-08
- Lead Sponsor
- E2Bio Life Sciences, LLC
- Target Recruit Count
- 100
- Registration Number
- NCT05338398
- Locations
- 🇦🇲
Hematology Center after Prof. R. Yeolyan, Yerevan, Armenia
Study of a New Medical Device for Oral Mucositis
Early Phase 1
Withdrawn
- Conditions
- Oral MucositisStem Cell Transplant Complications
- First Posted Date
- 2021-11-02
- Last Posted Date
- 2024-02-20
- Lead Sponsor
- E2Bio Life Sciences, LLC
- Registration Number
- NCT05104268
- Locations
- 🇦🇲
Hematology Center after Prof. R. Yeolyan MH RA, Yerevan, Armenia
News
No news found